Global Paroxysmal Nocturnal Hemoglobinuria Drug Supply, Demand and Key Producers, 2023-2029
The global Paroxysmal Nocturnal Hemoglobinuria Drug market size is expected to reach $ 7482 million by 2029, rising at a market growth of 12.4% CAGR during the forecast period (2023-2029).
This report studies the global Paroxysmal Nocturnal Hemoglobinuria Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Paroxysmal Nocturnal Hemoglobinuria Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Paroxysmal Nocturnal Hemoglobinuria Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Paroxysmal Nocturnal Hemoglobinuria Drug total production and demand, 2018-2029, (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria Drug total production value, 2018-2029, (USD Million)
Global Paroxysmal Nocturnal Hemoglobinuria Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Paroxysmal Nocturnal Hemoglobinuria Drug domestic production, consumption, key domestic manufacturers and share
Global Paroxysmal Nocturnal Hemoglobinuria Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Paroxysmal Nocturnal Hemoglobinuria Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Apellis Pharmaceuticals, Alexion Pharmaceuticals Inc, Akari Therapeutics Plc, CinnaGen Co, Ra Pharmaceuticals Inc, Amgen Inc, Achillion Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc and F. Hoffmann-La Roche Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Paroxysmal Nocturnal Hemoglobinuria Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Paroxysmal Nocturnal Hemoglobinuria Drug Market, By Region:
1. How big is the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
2. What is the demand of the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
3. What is the year over year growth of the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
4. What is the production and production value of the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
5. Who are the key producers in the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Paroxysmal Nocturnal Hemoglobinuria Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Paroxysmal Nocturnal Hemoglobinuria Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Paroxysmal Nocturnal Hemoglobinuria Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Paroxysmal Nocturnal Hemoglobinuria Drug total production and demand, 2018-2029, (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria Drug total production value, 2018-2029, (USD Million)
Global Paroxysmal Nocturnal Hemoglobinuria Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Paroxysmal Nocturnal Hemoglobinuria Drug domestic production, consumption, key domestic manufacturers and share
Global Paroxysmal Nocturnal Hemoglobinuria Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paroxysmal Nocturnal Hemoglobinuria Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Paroxysmal Nocturnal Hemoglobinuria Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Apellis Pharmaceuticals, Alexion Pharmaceuticals Inc, Akari Therapeutics Plc, CinnaGen Co, Ra Pharmaceuticals Inc, Amgen Inc, Achillion Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc and F. Hoffmann-La Roche Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Paroxysmal Nocturnal Hemoglobinuria Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Paroxysmal Nocturnal Hemoglobinuria Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Eculizumab
- Ravulizumab
- Others
- Clinic
- Hospital
- Others
- Apellis Pharmaceuticals
- Alexion Pharmaceuticals Inc
- Akari Therapeutics Plc
- CinnaGen Co
- Ra Pharmaceuticals Inc
- Amgen Inc
- Achillion Pharmaceuticals Inc
- Alnylam Pharmaceuticals Inc
- F. Hoffmann-La Roche Ltd
- Novartis AG
- Regeneron Pharmaceuticals Inc
- BIOCAD
- Samsung Bioepis
- Amyndas Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- LGM Pharma.
- Lannett
- NorthStar Rx LLC
- Abbott
- Par Pharmaceutical
1. How big is the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
2. What is the demand of the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
3. What is the year over year growth of the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
4. What is the production and production value of the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
5. Who are the key producers in the global Paroxysmal Nocturnal Hemoglobinuria Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Paroxysmal Nocturnal Hemoglobinuria Drug Introduction
1.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Supply & Forecast
1.2.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.2.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Pricing Trends (2018-2029)
1.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Region (Based on Production Site)
1.3.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Region (2018-2029)
1.3.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Region (2018-2029)
1.3.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Region (2018-2029)
1.3.4 North America Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.3.5 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.3.6 China Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.3.7 Japan Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Paroxysmal Nocturnal Hemoglobinuria Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Paroxysmal Nocturnal Hemoglobinuria Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Demand (2018-2029)
2.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption by Region
2.2.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption by Region (2018-2023)
2.2.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Forecast by Region (2024-2029)
2.3 United States Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.4 China Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.5 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.6 Japan Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.7 South Korea Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.8 ASEAN Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.9 India Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
3 WORLD PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Manufacturer (2018-2023)
3.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Manufacturer (2018-2023)
3.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Manufacturer (2018-2023)
3.4 Paroxysmal Nocturnal Hemoglobinuria Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Paroxysmal Nocturnal Hemoglobinuria Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Paroxysmal Nocturnal Hemoglobinuria Drug in 2022
3.6 Paroxysmal Nocturnal Hemoglobinuria Drug Market: Overall Company Footprint Analysis
3.6.1 Paroxysmal Nocturnal Hemoglobinuria Drug Market: Region Footprint
3.6.2 Paroxysmal Nocturnal Hemoglobinuria Drug Market: Company Product Type Footprint
3.6.3 Paroxysmal Nocturnal Hemoglobinuria Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Comparison
4.1.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Comparison
4.2.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Comparison
4.3.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023)
4.5 China Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers and Market Share
4.5.1 China Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023)
4.6 Rest of World Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Eculizumab
5.2.2 Ravulizumab
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Type (2018-2029)
5.3.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type (2018-2029)
5.3.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinic
6.2.2 Hospital
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Application (2018-2029)
6.3.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application (2018-2029)
6.3.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Apellis Pharmaceuticals
7.1.1 Apellis Pharmaceuticals Details
7.1.2 Apellis Pharmaceuticals Major Business
7.1.3 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.1.4 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Apellis Pharmaceuticals Recent Developments/Updates
7.1.6 Apellis Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Alexion Pharmaceuticals Inc
7.2.1 Alexion Pharmaceuticals Inc Details
7.2.2 Alexion Pharmaceuticals Inc Major Business
7.2.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.2.4 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Alexion Pharmaceuticals Inc Recent Developments/Updates
7.2.6 Alexion Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.3 Akari Therapeutics Plc
7.3.1 Akari Therapeutics Plc Details
7.3.2 Akari Therapeutics Plc Major Business
7.3.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.3.4 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Akari Therapeutics Plc Recent Developments/Updates
7.3.6 Akari Therapeutics Plc Competitive Strengths & Weaknesses
7.4 CinnaGen Co
7.4.1 CinnaGen Co Details
7.4.2 CinnaGen Co Major Business
7.4.3 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.4.4 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 CinnaGen Co Recent Developments/Updates
7.4.6 CinnaGen Co Competitive Strengths & Weaknesses
7.5 Ra Pharmaceuticals Inc
7.5.1 Ra Pharmaceuticals Inc Details
7.5.2 Ra Pharmaceuticals Inc Major Business
7.5.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.5.4 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ra Pharmaceuticals Inc Recent Developments/Updates
7.5.6 Ra Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.6 Amgen Inc
7.6.1 Amgen Inc Details
7.6.2 Amgen Inc Major Business
7.6.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.6.4 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Amgen Inc Recent Developments/Updates
7.6.6 Amgen Inc Competitive Strengths & Weaknesses
7.7 Achillion Pharmaceuticals Inc
7.7.1 Achillion Pharmaceuticals Inc Details
7.7.2 Achillion Pharmaceuticals Inc Major Business
7.7.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.7.4 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Achillion Pharmaceuticals Inc Recent Developments/Updates
7.7.6 Achillion Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.8 Alnylam Pharmaceuticals Inc
7.8.1 Alnylam Pharmaceuticals Inc Details
7.8.2 Alnylam Pharmaceuticals Inc Major Business
7.8.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.8.4 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Alnylam Pharmaceuticals Inc Recent Developments/Updates
7.8.6 Alnylam Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.9 F. Hoffmann-La Roche Ltd
7.9.1 F. Hoffmann-La Roche Ltd Details
7.9.2 F. Hoffmann-La Roche Ltd Major Business
7.9.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.9.4 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.9.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.10 Novartis AG
7.10.1 Novartis AG Details
7.10.2 Novartis AG Major Business
7.10.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.10.4 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Novartis AG Recent Developments/Updates
7.10.6 Novartis AG Competitive Strengths & Weaknesses
7.11 Regeneron Pharmaceuticals Inc
7.11.1 Regeneron Pharmaceuticals Inc Details
7.11.2 Regeneron Pharmaceuticals Inc Major Business
7.11.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.11.4 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
7.11.6 Regeneron Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.12 BIOCAD
7.12.1 BIOCAD Details
7.12.2 BIOCAD Major Business
7.12.3 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.12.4 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 BIOCAD Recent Developments/Updates
7.12.6 BIOCAD Competitive Strengths & Weaknesses
7.13 Samsung Bioepis
7.13.1 Samsung Bioepis Details
7.13.2 Samsung Bioepis Major Business
7.13.3 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.13.4 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Samsung Bioepis Recent Developments/Updates
7.13.6 Samsung Bioepis Competitive Strengths & Weaknesses
7.14 Amyndas Pharmaceuticals
7.14.1 Amyndas Pharmaceuticals Details
7.14.2 Amyndas Pharmaceuticals Major Business
7.14.3 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.14.4 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Amyndas Pharmaceuticals Recent Developments/Updates
7.14.6 Amyndas Pharmaceuticals Competitive Strengths & Weaknesses
7.15 Teva Pharmaceutical Industries Ltd.
7.15.1 Teva Pharmaceutical Industries Ltd. Details
7.15.2 Teva Pharmaceutical Industries Ltd. Major Business
7.15.3 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.15.4 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.15.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.16 LGM Pharma.
7.16.1 LGM Pharma. Details
7.16.2 LGM Pharma. Major Business
7.16.3 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.16.4 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 LGM Pharma. Recent Developments/Updates
7.16.6 LGM Pharma. Competitive Strengths & Weaknesses
7.17 Lannett
7.17.1 Lannett Details
7.17.2 Lannett Major Business
7.17.3 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.17.4 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Lannett Recent Developments/Updates
7.17.6 Lannett Competitive Strengths & Weaknesses
7.18 NorthStar Rx LLC
7.18.1 NorthStar Rx LLC Details
7.18.2 NorthStar Rx LLC Major Business
7.18.3 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.18.4 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 NorthStar Rx LLC Recent Developments/Updates
7.18.6 NorthStar Rx LLC Competitive Strengths & Weaknesses
7.19 Abbott
7.19.1 Abbott Details
7.19.2 Abbott Major Business
7.19.3 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.19.4 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Abbott Recent Developments/Updates
7.19.6 Abbott Competitive Strengths & Weaknesses
7.20 Par Pharmaceutical
7.20.1 Par Pharmaceutical Details
7.20.2 Par Pharmaceutical Major Business
7.20.3 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.20.4 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Par Pharmaceutical Recent Developments/Updates
7.20.6 Par Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Paroxysmal Nocturnal Hemoglobinuria Drug Industry Chain
8.2 Paroxysmal Nocturnal Hemoglobinuria Drug Upstream Analysis
8.2.1 Paroxysmal Nocturnal Hemoglobinuria Drug Core Raw Materials
8.2.2 Main Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Paroxysmal Nocturnal Hemoglobinuria Drug Production Mode
8.6 Paroxysmal Nocturnal Hemoglobinuria Drug Procurement Model
8.7 Paroxysmal Nocturnal Hemoglobinuria Drug Industry Sales Model and Sales Channels
8.7.1 Paroxysmal Nocturnal Hemoglobinuria Drug Sales Model
8.7.2 Paroxysmal Nocturnal Hemoglobinuria Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Paroxysmal Nocturnal Hemoglobinuria Drug Introduction
1.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Supply & Forecast
1.2.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.2.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Pricing Trends (2018-2029)
1.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Region (Based on Production Site)
1.3.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Region (2018-2029)
1.3.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Region (2018-2029)
1.3.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Region (2018-2029)
1.3.4 North America Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.3.5 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.3.6 China Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.3.7 Japan Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Paroxysmal Nocturnal Hemoglobinuria Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Paroxysmal Nocturnal Hemoglobinuria Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Demand (2018-2029)
2.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption by Region
2.2.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption by Region (2018-2023)
2.2.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Forecast by Region (2024-2029)
2.3 United States Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.4 China Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.5 Europe Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.6 Japan Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.7 South Korea Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.8 ASEAN Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
2.9 India Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029)
3 WORLD PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Manufacturer (2018-2023)
3.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Manufacturer (2018-2023)
3.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Manufacturer (2018-2023)
3.4 Paroxysmal Nocturnal Hemoglobinuria Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Paroxysmal Nocturnal Hemoglobinuria Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Paroxysmal Nocturnal Hemoglobinuria Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Paroxysmal Nocturnal Hemoglobinuria Drug in 2022
3.6 Paroxysmal Nocturnal Hemoglobinuria Drug Market: Overall Company Footprint Analysis
3.6.1 Paroxysmal Nocturnal Hemoglobinuria Drug Market: Region Footprint
3.6.2 Paroxysmal Nocturnal Hemoglobinuria Drug Market: Company Product Type Footprint
3.6.3 Paroxysmal Nocturnal Hemoglobinuria Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Comparison
4.1.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Comparison
4.2.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Comparison
4.3.1 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023)
4.5 China Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers and Market Share
4.5.1 China Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023)
4.6 Rest of World Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Eculizumab
5.2.2 Ravulizumab
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Type (2018-2029)
5.3.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type (2018-2029)
5.3.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinic
6.2.2 Hospital
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Application (2018-2029)
6.3.2 World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application (2018-2029)
6.3.3 World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Apellis Pharmaceuticals
7.1.1 Apellis Pharmaceuticals Details
7.1.2 Apellis Pharmaceuticals Major Business
7.1.3 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.1.4 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Apellis Pharmaceuticals Recent Developments/Updates
7.1.6 Apellis Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Alexion Pharmaceuticals Inc
7.2.1 Alexion Pharmaceuticals Inc Details
7.2.2 Alexion Pharmaceuticals Inc Major Business
7.2.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.2.4 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Alexion Pharmaceuticals Inc Recent Developments/Updates
7.2.6 Alexion Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.3 Akari Therapeutics Plc
7.3.1 Akari Therapeutics Plc Details
7.3.2 Akari Therapeutics Plc Major Business
7.3.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.3.4 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Akari Therapeutics Plc Recent Developments/Updates
7.3.6 Akari Therapeutics Plc Competitive Strengths & Weaknesses
7.4 CinnaGen Co
7.4.1 CinnaGen Co Details
7.4.2 CinnaGen Co Major Business
7.4.3 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.4.4 CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 CinnaGen Co Recent Developments/Updates
7.4.6 CinnaGen Co Competitive Strengths & Weaknesses
7.5 Ra Pharmaceuticals Inc
7.5.1 Ra Pharmaceuticals Inc Details
7.5.2 Ra Pharmaceuticals Inc Major Business
7.5.3 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.5.4 Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ra Pharmaceuticals Inc Recent Developments/Updates
7.5.6 Ra Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.6 Amgen Inc
7.6.1 Amgen Inc Details
7.6.2 Amgen Inc Major Business
7.6.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.6.4 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Amgen Inc Recent Developments/Updates
7.6.6 Amgen Inc Competitive Strengths & Weaknesses
7.7 Achillion Pharmaceuticals Inc
7.7.1 Achillion Pharmaceuticals Inc Details
7.7.2 Achillion Pharmaceuticals Inc Major Business
7.7.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.7.4 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Achillion Pharmaceuticals Inc Recent Developments/Updates
7.7.6 Achillion Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.8 Alnylam Pharmaceuticals Inc
7.8.1 Alnylam Pharmaceuticals Inc Details
7.8.2 Alnylam Pharmaceuticals Inc Major Business
7.8.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.8.4 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Alnylam Pharmaceuticals Inc Recent Developments/Updates
7.8.6 Alnylam Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.9 F. Hoffmann-La Roche Ltd
7.9.1 F. Hoffmann-La Roche Ltd Details
7.9.2 F. Hoffmann-La Roche Ltd Major Business
7.9.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.9.4 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.9.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.10 Novartis AG
7.10.1 Novartis AG Details
7.10.2 Novartis AG Major Business
7.10.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.10.4 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Novartis AG Recent Developments/Updates
7.10.6 Novartis AG Competitive Strengths & Weaknesses
7.11 Regeneron Pharmaceuticals Inc
7.11.1 Regeneron Pharmaceuticals Inc Details
7.11.2 Regeneron Pharmaceuticals Inc Major Business
7.11.3 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.11.4 Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
7.11.6 Regeneron Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.12 BIOCAD
7.12.1 BIOCAD Details
7.12.2 BIOCAD Major Business
7.12.3 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.12.4 BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 BIOCAD Recent Developments/Updates
7.12.6 BIOCAD Competitive Strengths & Weaknesses
7.13 Samsung Bioepis
7.13.1 Samsung Bioepis Details
7.13.2 Samsung Bioepis Major Business
7.13.3 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.13.4 Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Samsung Bioepis Recent Developments/Updates
7.13.6 Samsung Bioepis Competitive Strengths & Weaknesses
7.14 Amyndas Pharmaceuticals
7.14.1 Amyndas Pharmaceuticals Details
7.14.2 Amyndas Pharmaceuticals Major Business
7.14.3 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.14.4 Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Amyndas Pharmaceuticals Recent Developments/Updates
7.14.6 Amyndas Pharmaceuticals Competitive Strengths & Weaknesses
7.15 Teva Pharmaceutical Industries Ltd.
7.15.1 Teva Pharmaceutical Industries Ltd. Details
7.15.2 Teva Pharmaceutical Industries Ltd. Major Business
7.15.3 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.15.4 Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.15.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.16 LGM Pharma.
7.16.1 LGM Pharma. Details
7.16.2 LGM Pharma. Major Business
7.16.3 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.16.4 LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 LGM Pharma. Recent Developments/Updates
7.16.6 LGM Pharma. Competitive Strengths & Weaknesses
7.17 Lannett
7.17.1 Lannett Details
7.17.2 Lannett Major Business
7.17.3 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.17.4 Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Lannett Recent Developments/Updates
7.17.6 Lannett Competitive Strengths & Weaknesses
7.18 NorthStar Rx LLC
7.18.1 NorthStar Rx LLC Details
7.18.2 NorthStar Rx LLC Major Business
7.18.3 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.18.4 NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 NorthStar Rx LLC Recent Developments/Updates
7.18.6 NorthStar Rx LLC Competitive Strengths & Weaknesses
7.19 Abbott
7.19.1 Abbott Details
7.19.2 Abbott Major Business
7.19.3 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.19.4 Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Abbott Recent Developments/Updates
7.19.6 Abbott Competitive Strengths & Weaknesses
7.20 Par Pharmaceutical
7.20.1 Par Pharmaceutical Details
7.20.2 Par Pharmaceutical Major Business
7.20.3 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
7.20.4 Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Par Pharmaceutical Recent Developments/Updates
7.20.6 Par Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Paroxysmal Nocturnal Hemoglobinuria Drug Industry Chain
8.2 Paroxysmal Nocturnal Hemoglobinuria Drug Upstream Analysis
8.2.1 Paroxysmal Nocturnal Hemoglobinuria Drug Core Raw Materials
8.2.2 Main Manufacturers of Paroxysmal Nocturnal Hemoglobinuria Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Paroxysmal Nocturnal Hemoglobinuria Drug Production Mode
8.6 Paroxysmal Nocturnal Hemoglobinuria Drug Procurement Model
8.7 Paroxysmal Nocturnal Hemoglobinuria Drug Industry Sales Model and Sales Channels
8.7.1 Paroxysmal Nocturnal Hemoglobinuria Drug Sales Model
8.7.2 Paroxysmal Nocturnal Hemoglobinuria Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Region (2018-2023)
Table 5. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Region (2024-2029)
Table 6. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Region (2018-2023) & (K Units)
Table 7. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Region (2024-2029) & (K Units)
Table 8. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Region (2018-2023)
Table 9. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Region (2024-2029)
Table 10. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Paroxysmal Nocturnal Hemoglobinuria Drug Major Market Trends
Table 13. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Paroxysmal Nocturnal Hemoglobinuria Drug Producers in 2022
Table 18. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Paroxysmal Nocturnal Hemoglobinuria Drug Producers in 2022
Table 20. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Paroxysmal Nocturnal Hemoglobinuria Drug Company Evaluation Quadrant
Table 22. World Paroxysmal Nocturnal Hemoglobinuria Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Paroxysmal Nocturnal Hemoglobinuria Drug Production Site of Key Manufacturer
Table 24. Paroxysmal Nocturnal Hemoglobinuria Drug Market: Company Product Type Footprint
Table 25. Paroxysmal Nocturnal Hemoglobinuria Drug Market: Company Product Application Footprint
Table 26. Paroxysmal Nocturnal Hemoglobinuria Drug Competitive Factors
Table 27. Paroxysmal Nocturnal Hemoglobinuria Drug New Entrant and Capacity Expansion Plans
Table 28. Paroxysmal Nocturnal Hemoglobinuria Drug Mergers & Acquisitions Activity
Table 29. United States VS China Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Paroxysmal Nocturnal Hemoglobinuria Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share (2018-2023)
Table 37. China Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share (2018-2023)
Table 47. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Type (2018-2023) & (K Units)
Table 49. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Type (2024-2029) & (K Units)
Table 50. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Application (2018-2023) & (K Units)
Table 56. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Application (2024-2029) & (K Units)
Table 57. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Apellis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Apellis Pharmaceuticals Major Business
Table 63. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 64. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Apellis Pharmaceuticals Recent Developments/Updates
Table 66. Apellis Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Alexion Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 68. Alexion Pharmaceuticals Inc Major Business
Table 69. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 70. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Alexion Pharmaceuticals Inc Recent Developments/Updates
Table 72. Alexion Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 73. Akari Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table 74. Akari Therapeutics Plc Major Business
Table 75. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 76. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Akari Therapeutics Plc Recent Developments/Updates
Table 78. Akari Therapeutics Plc Competitive Strengths & Weaknesses
Table 79. CinnaGen Co Basic Information, Manufacturing Base and Competitors
Table 80. CinnaGen Co Major Business
Table 81. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 82. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. CinnaGen Co Recent Developments/Updates
Table 84. CinnaGen Co Competitive Strengths & Weaknesses
Table 85. Ra Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 86. Ra Pharmaceuticals Inc Major Business
Table 87. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 88. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ra Pharmaceuticals Inc Recent Developments/Updates
Table 90. Ra Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 91. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 92. Amgen Inc Major Business
Table 93. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 94. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Amgen Inc Recent Developments/Updates
Table 96. Amgen Inc Competitive Strengths & Weaknesses
Table 97. Achillion Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 98. Achillion Pharmaceuticals Inc Major Business
Table 99. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 100. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Achillion Pharmaceuticals Inc Recent Developments/Updates
Table 102. Achillion Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 103. Alnylam Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 104. Alnylam Pharmaceuticals Inc Major Business
Table 105. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 106. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Alnylam Pharmaceuticals Inc Recent Developments/Updates
Table 108. Alnylam Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 109. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 110. F. Hoffmann-La Roche Ltd Major Business
Table 111. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 112. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 114. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 115. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 116. Novartis AG Major Business
Table 117. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 118. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Novartis AG Recent Developments/Updates
Table 120. Novartis AG Competitive Strengths & Weaknesses
Table 121. Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 122. Regeneron Pharmaceuticals Inc Major Business
Table 123. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 124. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Regeneron Pharmaceuticals Inc Recent Developments/Updates
Table 126. Regeneron Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 127. BIOCAD Basic Information, Manufacturing Base and Competitors
Table 128. BIOCAD Major Business
Table 129. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 130. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. BIOCAD Recent Developments/Updates
Table 132. BIOCAD Competitive Strengths & Weaknesses
Table 133. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 134. Samsung Bioepis Major Business
Table 135. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 136. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Samsung Bioepis Recent Developments/Updates
Table 138. Samsung Bioepis Competitive Strengths & Weaknesses
Table 139. Amyndas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 140. Amyndas Pharmaceuticals Major Business
Table 141. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 142. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Amyndas Pharmaceuticals Recent Developments/Updates
Table 144. Amyndas Pharmaceuticals Competitive Strengths & Weaknesses
Table 145. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 146. Teva Pharmaceutical Industries Ltd. Major Business
Table 147. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 148. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 150. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 151. LGM Pharma. Basic Information, Manufacturing Base and Competitors
Table 152. LGM Pharma. Major Business
Table 153. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 154. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. LGM Pharma. Recent Developments/Updates
Table 156. LGM Pharma. Competitive Strengths & Weaknesses
Table 157. Lannett Basic Information, Manufacturing Base and Competitors
Table 158. Lannett Major Business
Table 159. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 160. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Lannett Recent Developments/Updates
Table 162. Lannett Competitive Strengths & Weaknesses
Table 163. NorthStar Rx LLC Basic Information, Manufacturing Base and Competitors
Table 164. NorthStar Rx LLC Major Business
Table 165. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 166. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. NorthStar Rx LLC Recent Developments/Updates
Table 168. NorthStar Rx LLC Competitive Strengths & Weaknesses
Table 169. Abbott Basic Information, Manufacturing Base and Competitors
Table 170. Abbott Major Business
Table 171. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 172. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Abbott Recent Developments/Updates
Table 174. Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 175. Par Pharmaceutical Major Business
Table 176. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 177. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Paroxysmal Nocturnal Hemoglobinuria Drug Upstream (Raw Materials)
Table 179. Paroxysmal Nocturnal Hemoglobinuria Drug Typical Customers
Table 180. Paroxysmal Nocturnal Hemoglobinuria Drug Typical Distributors
Table 1. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Region (2018-2023)
Table 5. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Region (2024-2029)
Table 6. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Region (2018-2023) & (K Units)
Table 7. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Region (2024-2029) & (K Units)
Table 8. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Region (2018-2023)
Table 9. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Region (2024-2029)
Table 10. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Paroxysmal Nocturnal Hemoglobinuria Drug Major Market Trends
Table 13. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Paroxysmal Nocturnal Hemoglobinuria Drug Producers in 2022
Table 18. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Paroxysmal Nocturnal Hemoglobinuria Drug Producers in 2022
Table 20. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Paroxysmal Nocturnal Hemoglobinuria Drug Company Evaluation Quadrant
Table 22. World Paroxysmal Nocturnal Hemoglobinuria Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Paroxysmal Nocturnal Hemoglobinuria Drug Production Site of Key Manufacturer
Table 24. Paroxysmal Nocturnal Hemoglobinuria Drug Market: Company Product Type Footprint
Table 25. Paroxysmal Nocturnal Hemoglobinuria Drug Market: Company Product Application Footprint
Table 26. Paroxysmal Nocturnal Hemoglobinuria Drug Competitive Factors
Table 27. Paroxysmal Nocturnal Hemoglobinuria Drug New Entrant and Capacity Expansion Plans
Table 28. Paroxysmal Nocturnal Hemoglobinuria Drug Mergers & Acquisitions Activity
Table 29. United States VS China Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Paroxysmal Nocturnal Hemoglobinuria Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share (2018-2023)
Table 37. China Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Paroxysmal Nocturnal Hemoglobinuria Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share (2018-2023)
Table 47. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Type (2018-2023) & (K Units)
Table 49. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Type (2024-2029) & (K Units)
Table 50. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Application (2018-2023) & (K Units)
Table 56. World Paroxysmal Nocturnal Hemoglobinuria Drug Production by Application (2024-2029) & (K Units)
Table 57. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Apellis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Apellis Pharmaceuticals Major Business
Table 63. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 64. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Apellis Pharmaceuticals Recent Developments/Updates
Table 66. Apellis Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Alexion Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 68. Alexion Pharmaceuticals Inc Major Business
Table 69. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 70. Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Alexion Pharmaceuticals Inc Recent Developments/Updates
Table 72. Alexion Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 73. Akari Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table 74. Akari Therapeutics Plc Major Business
Table 75. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 76. Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Akari Therapeutics Plc Recent Developments/Updates
Table 78. Akari Therapeutics Plc Competitive Strengths & Weaknesses
Table 79. CinnaGen Co Basic Information, Manufacturing Base and Competitors
Table 80. CinnaGen Co Major Business
Table 81. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 82. CinnaGen Co Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. CinnaGen Co Recent Developments/Updates
Table 84. CinnaGen Co Competitive Strengths & Weaknesses
Table 85. Ra Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 86. Ra Pharmaceuticals Inc Major Business
Table 87. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 88. Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ra Pharmaceuticals Inc Recent Developments/Updates
Table 90. Ra Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 91. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 92. Amgen Inc Major Business
Table 93. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 94. Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Amgen Inc Recent Developments/Updates
Table 96. Amgen Inc Competitive Strengths & Weaknesses
Table 97. Achillion Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 98. Achillion Pharmaceuticals Inc Major Business
Table 99. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 100. Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Achillion Pharmaceuticals Inc Recent Developments/Updates
Table 102. Achillion Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 103. Alnylam Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 104. Alnylam Pharmaceuticals Inc Major Business
Table 105. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 106. Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Alnylam Pharmaceuticals Inc Recent Developments/Updates
Table 108. Alnylam Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 109. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 110. F. Hoffmann-La Roche Ltd Major Business
Table 111. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 112. F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 114. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 115. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 116. Novartis AG Major Business
Table 117. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 118. Novartis AG Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Novartis AG Recent Developments/Updates
Table 120. Novartis AG Competitive Strengths & Weaknesses
Table 121. Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 122. Regeneron Pharmaceuticals Inc Major Business
Table 123. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 124. Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Regeneron Pharmaceuticals Inc Recent Developments/Updates
Table 126. Regeneron Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 127. BIOCAD Basic Information, Manufacturing Base and Competitors
Table 128. BIOCAD Major Business
Table 129. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 130. BIOCAD Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. BIOCAD Recent Developments/Updates
Table 132. BIOCAD Competitive Strengths & Weaknesses
Table 133. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 134. Samsung Bioepis Major Business
Table 135. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 136. Samsung Bioepis Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Samsung Bioepis Recent Developments/Updates
Table 138. Samsung Bioepis Competitive Strengths & Weaknesses
Table 139. Amyndas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 140. Amyndas Pharmaceuticals Major Business
Table 141. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 142. Amyndas Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Amyndas Pharmaceuticals Recent Developments/Updates
Table 144. Amyndas Pharmaceuticals Competitive Strengths & Weaknesses
Table 145. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 146. Teva Pharmaceutical Industries Ltd. Major Business
Table 147. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 148. Teva Pharmaceutical Industries Ltd. Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 150. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 151. LGM Pharma. Basic Information, Manufacturing Base and Competitors
Table 152. LGM Pharma. Major Business
Table 153. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 154. LGM Pharma. Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. LGM Pharma. Recent Developments/Updates
Table 156. LGM Pharma. Competitive Strengths & Weaknesses
Table 157. Lannett Basic Information, Manufacturing Base and Competitors
Table 158. Lannett Major Business
Table 159. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 160. Lannett Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Lannett Recent Developments/Updates
Table 162. Lannett Competitive Strengths & Weaknesses
Table 163. NorthStar Rx LLC Basic Information, Manufacturing Base and Competitors
Table 164. NorthStar Rx LLC Major Business
Table 165. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 166. NorthStar Rx LLC Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. NorthStar Rx LLC Recent Developments/Updates
Table 168. NorthStar Rx LLC Competitive Strengths & Weaknesses
Table 169. Abbott Basic Information, Manufacturing Base and Competitors
Table 170. Abbott Major Business
Table 171. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 172. Abbott Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Abbott Recent Developments/Updates
Table 174. Par Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 175. Par Pharmaceutical Major Business
Table 176. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Product and Services
Table 177. Par Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Paroxysmal Nocturnal Hemoglobinuria Drug Upstream (Raw Materials)
Table 179. Paroxysmal Nocturnal Hemoglobinuria Drug Typical Customers
Table 180. Paroxysmal Nocturnal Hemoglobinuria Drug Typical Distributors
LIST OF FIGURES
Figure 1. Paroxysmal Nocturnal Hemoglobinuria Drug Picture
Figure 2. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 5. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Region (2018-2029)
Figure 8. North America Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 9. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 10. China Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 11. Japan Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 12. Paroxysmal Nocturnal Hemoglobinuria Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 15. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 17. China Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 22. India Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Paroxysmal Nocturnal Hemoglobinuria Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Paroxysmal Nocturnal Hemoglobinuria Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Paroxysmal Nocturnal Hemoglobinuria Drug Markets in 2022
Figure 26. United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share 2022
Figure 30. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share 2022
Figure 32. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Type in 2022
Figure 34. Eculizumab
Figure 35. Ravulizumab
Figure 36. Others
Figure 37. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Type (2018-2029)
Figure 38. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Application in 2022
Figure 42. Clinic
Figure 43. Hospital
Figure 44. Others
Figure 45. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Application (2018-2029)
Figure 46. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Application (2018-2029)
Figure 47. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Paroxysmal Nocturnal Hemoglobinuria Drug Industry Chain
Figure 49. Paroxysmal Nocturnal Hemoglobinuria Drug Procurement Model
Figure 50. Paroxysmal Nocturnal Hemoglobinuria Drug Sales Model
Figure 51. Paroxysmal Nocturnal Hemoglobinuria Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Paroxysmal Nocturnal Hemoglobinuria Drug Picture
Figure 2. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 5. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Region (2018-2029)
Figure 8. North America Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 9. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 10. China Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 11. Japan Paroxysmal Nocturnal Hemoglobinuria Drug Production (2018-2029) & (K Units)
Figure 12. Paroxysmal Nocturnal Hemoglobinuria Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 15. World Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 17. China Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 22. India Paroxysmal Nocturnal Hemoglobinuria Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Paroxysmal Nocturnal Hemoglobinuria Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Paroxysmal Nocturnal Hemoglobinuria Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Paroxysmal Nocturnal Hemoglobinuria Drug Markets in 2022
Figure 26. United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Paroxysmal Nocturnal Hemoglobinuria Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share 2022
Figure 30. China Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share 2022
Figure 32. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Type in 2022
Figure 34. Eculizumab
Figure 35. Ravulizumab
Figure 36. Others
Figure 37. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Type (2018-2029)
Figure 38. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Application in 2022
Figure 42. Clinic
Figure 43. Hospital
Figure 44. Others
Figure 45. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Market Share by Application (2018-2029)
Figure 46. World Paroxysmal Nocturnal Hemoglobinuria Drug Production Value Market Share by Application (2018-2029)
Figure 47. World Paroxysmal Nocturnal Hemoglobinuria Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Paroxysmal Nocturnal Hemoglobinuria Drug Industry Chain
Figure 49. Paroxysmal Nocturnal Hemoglobinuria Drug Procurement Model
Figure 50. Paroxysmal Nocturnal Hemoglobinuria Drug Sales Model
Figure 51. Paroxysmal Nocturnal Hemoglobinuria Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
